RELATED STUDY

Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke

Key Findings:  CBD exerts positive pharmacological effects in ischemic stroke and other chronic diseases, including Parkinson’s disease, Alzheimer’s disease, and rheumatoid arthritis. The cerebroprotective action of CBD is CB1 receptor-independent, long-lasting, and has potent anti-oxidant activity.

Type of Study:  Meta-analysis

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable

Receptors Studied:  CB1, CB2


Study Location(s):  Japan

Year of Pub:  2010


Link to study